Learning Objectives:

  1. Learn about rising drugs costs and the new discipline of interventional pharmacoeconomics (IVPE).
  2. See how the IVPE substitution strategy can be applied to LHRH therapy in prostate cancer to encourage a reduction in drug costs.
  3. Explore how the IVPE less frequent dosing strategy can be applied to nivolumab and pembrolizumab to reduce drug costs.
Session date: 
02/03/2020 - 12:00pm to 1:00pm CST
900 East 57th Street
KCBD Auditorium 1103
Chicago, IL 60637
United States
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 Participation

Please login or create an account to proceed.
Speaker Name: 
Brian L. Heiss, MD